PATENT CLAIM ANALYSIS

Application Number: 16129618
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "133100"]

Abstract:
The invention provides antibodies that specifically bind transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.

Claim (Index 49):
The antibody of  claim 48 , wherein the binding fragment is a single-chain antibody, Fab, or Fab\u20322 fragment.

Metadata:
- Claim Count in Document: 273.0
- Percentile: 97.0
- Lexical Diversity: 1.64103
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15201423', '15201416', '15201429', '15861600', '15199236']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8654353727944697
- 35 USC 102 Novelty (BERT): 0.6943637667764079
- Combined Prediction Score: 0.8483282121926635
- Mean Citation Score: 697.8904719999997
- Max Citation Score: 812.8804
- Similarity Product: 694.5340572032927

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test